Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07818967 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Abemaciclib (LY2835219) in Healthy Participants

Name: A Study of Abemaciclib (LY2835219) in Healthy Participants — clinical trial record (NCT07818967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-09

View on ClinicalTrials.gov ↗

The main purpose of this study is to compare different forms of abemaciclib (LY2835219) to see how much and how quickly each gets into the bloodstream after it is swallowed, and to check for any side effects. For each participant, the study will last about 12 weeks and will include 3 stays in the Clinical Research Unit (CRU). Each stay will last 10 days.

Trial Details

NCT Number	NCT07818967
Lead Sponsor	Eli Lilly and Company
Conditions	Healthy Volunteers
Enrollment	15 participants
Start Date	2026-09
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-09-14